Hundreds of businesses have pulled out of Russia following its invasion of Ukraine, but the decision is more complicated for pharmaceutical companies. Today, we dig into the ethical and economic considerations they’re facing. Plus: We talk with a former Ukrainian finance minister, track the nickel market’s wild ride and take stock of the tough job ahead for the Federal Reserve.

Keep independent journalism going strong. Give today to support Marketplace.